Barclays PLC — M&A Activity 2023

Oct 9, 2023

National Storage Mechanism | Additional information

RNS Number : 4572P

Barclays PLC

09 October 2023

FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1.				KEY INFORMATION
Name of person dealing (Note 1)				Barclays PLC.
Company dealt in				HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)				$0.001 ordinary shares
Date of dealing				06 Oct 2023
2.				INTERESTS AND SHORT POSITIONS
(a)	Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security:				$0.001 ordinary shares
				Long		Short
Number	(%)	Number	(%)
(1)	Relevant securities			126,460	0.06%	58,082	0.03%
(2)	Derivatives (other than options):			0	0.00%	0	0.00%
(3)	Options and agreements to purchase/sell:			0	0.00%	0	0.00%
TOTAL:				126,460	0.06%	58,082	0.03%
(b)	Interests and short positions in relevant securities of the company, other than the class dealt in
Class of relevant security:				Long		Short
Number	(%)	Number	(%)
(1)	Relevant securities
(2)	Derivatives (other than options):
(3)	Options and agreements to purchase/sell:
TOTAL:
3.				DEALINGS (Note 4)
(a)	Purchase and sales
Class of relevant Security			Purchase/sale			Number of securities	Price per unit
(b)	Derivatives transactions (other than option transactions)
Product Name		Nature of transaction				Number of relevant securities	Price per unit
(c)	Options transactions in respect of existing securities
(i)	Writing, selling, purchasing or varying
Class  of  relevant  security	Product  description	Writing,  purchasing,  selling,  varying etc	Number  of  securities  to which  option  relates	Exercise  price per unit	Type	Expiry  date	Option  money  paid/  received  per unit
(ii)	Exercising
Product name			Number of  securities			Exercise price  per unit
(d)	Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction				Details		Price per unit  (if applicable)
4.				OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing  and any other person relating to the voting rights of any relevant securities under any option  referred to on this form or relating to the voting rights or future acquisition or disposal of any  relevant securities to which any derivative referred to on this form is referenced. If none, this  should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				09 Oct 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPMZMGGDLVGFZM